Post-Transplant and In-Hospital Risk Factors for ARDS After Hematopoietic Stem Cell Transplantation

REFERENCES

1. 1.↵
   1. Afessa B,
   2. Abdulai RM,
   3. Kremers WK,
   4. Hogan WJ,
   5. Litzow MR,
   6. Peters SG

   . Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest 2012;141(2):442-450.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Yadav H,
   2. Nolan ME,
   3. Bohman JK,
   4. Cartin-Ceba R,
   5. Peters SG,
   6. Hogan WJ,
   7. et al

   . Epidemiology of acute respiratory distress syndrome following hematopoietic stem cell transplantation. Crit Care Med 2016;44(6):1082-1090.

   OpenUrl
3. 3.
   1. Bellani G,
   2. Laffey JG,
   3. Pham T,
   4. Fan E,
   5. Brochard L,
   6. Esteban A,
   7. et al

   ; ESICM Trials Group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788-800.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Herasevich S,
   2. Frank RD,
   3. Bo H,
   4. Alkhateeb H,
   5. Hogan WJ,
   6. Gajic O,
   7. et al

   . Pretransplant risk factors can predict development of acute respiratory distress syndrome after hematopoietic stem cell transplantation. Ann Am Thorac Soc 2021;18(6):1004-1012.

   OpenUrl
5. 5.↵
   1. Darmon M,
   2. Bourmaud A,
   3. Georges Q,
   4. Soares M,
   5. Jeon K,
   6. Oeyen S,
   7. et al

   . Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 2019;45(7):977-987.

   OpenUrlPubMed
6. 6.↵
   1. Cochi SE,
   2. Kempker JA,
   3. Annangi S,
   4. Kramer MR,
   5. Martin GS

   . Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013. Ann Am Thorac Soc 2016;13(10):1742-1751.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Ahmed AH,
   2. Litell JM,
   3. Malinchoc M,
   4. Kashyap R,
   5. Schiller HJ,
   6. Pannu SR,
   7. et al

   . The role of potentially preventable hospital exposures in the development of acute respiratory distress syndrome: a population-based study. Crit Care Med 2014;42(1):31-39.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Gajic O,
   2. Dabbagh O,
   3. Park PK,
   4. Adesanya A,
   5. Chang SY,
   6. Hou P,
   7. et al

   ; U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multi-center cohort study. Am J Respir Crit Care Med 2011;183(4):462-470.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Ranieri VM,
   2. Rubenfeld GD,
   3. Thompson BT,
   4. Ferguson ND,
   5. Caldwell E,
   6. Fan E,
   7. et al

   ; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012;307(23):2526-2533.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Li G,
    2. Malinchoc M,
    3. Cartin-Ceba R,
    4. Venkata CV,
    5. Kor DJ,
    6. Peters SG,
    7. et al

    . Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011;183(1):59-66.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Singer M,
    2. Deutschman CS,
    3. Seymour CW,
    4. Shankar-Hari M,
    5. Annane D,
    6. Bauer M,
    7. et al

    . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315(8):801-810.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Aakre C,
    2. Franco PM,
    3. Ferreyra M,
    4. Kitson J,
    5. Li M,
    6. Herasevich V

    . Prospective validation of a near real-time EHR-integrated automated SOFA score calculator. Int J Med Inform 2017;103:1-6.

    OpenUrlCrossRef
13. 13.↵
    1. Soto GJ,
    2. Kor DJ,
    3. Park PK,
    4. Hou PC,
    5. Kaufman DA,
    6. Kim M,
    7. et al

    . Lung injury prediction score in hospitalized patients at risk of acute respiratory distress syndrome. Crit Care Med 2016;44(12):2182-2191.

    OpenUrlPubMed
14. 14.↵
    1. Wieruszewski PM,
    2. May HP,
    3. Peters SG,
    4. Gajic O,
    5. Hogan WJ,
    6. Dierkhising RA,
    7. et al

    . Characteristics and outcome of peri-engraftment respiratory distress syndrome after autologous hematopoietic cell transplant. Ann Am Thorac Soc 2021;18(6):1013-1019.

    OpenUrl
15. 15.↵
    1. Zhang Z,
    2. Wang C,
    3. Peters SG,
    4. Hogan WJ,
    5. Hashmi SK,
    6. Litzow MR,
    7. et al

    . Epidemiology, risk factors, and outcomes of diffuse alveolar hemorrhage after hematopoietic stem cell transplantation. Chest 2021;159(6):2325-2333.

    OpenUrl
16. 16.↵
    1. Afessa B,
    2. Litzow MR,
    3. Tefferi A

    . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;28(5):425-434.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Chi AK,
    2. Soubani AO,
    3. White AC,
    4. Miller KB

    . An update on pulmonary complications of hematopoietic stem cell transplantation. Chest 2013;144(6):1913-1922.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Haider S,
    2. Durairajan N,
    3. Soubani AO

    . Non-infectious pulmonary complications of hematopoietic stem cell transplantation. Eur Respir Rev 2020;29(156):190119.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Brower RG,
    2. Matthay MA,
    3. Morris A,
    4. Schoenfeld D,
    5. Thompson BT,
    6. et al

    Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-1308.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.
    1. Amato MB,
    2. Meade MO,
    3. Slutsky AS,
    4. Brochard L,
    5. Costa EL,
    6. Schoenfeld DA,
    7. et al

    . Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015;372(8):747-755.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Wiedemann HP,
    2. Wheeler AP,
    3. Bernard GR,
    4. Thompson BT,
    5. et al

    ; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Comparison of two fluid management strategies in acute lung injury. N Engl J Med 2006;354(24):2564-2575.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.
    1. Guerin C,
    2. Reignier J,
    3. Richard JC,
    4. Beuret P,
    5. Gacouin A,
    6. Boulain T,
    7. et al

    . Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013;368(23):2159-2168.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Papazian L,
    2. Forel JM,
    3. Gacouin A,
    4. Penot-Ragon C,
    5. Perrin G,
    6. Loundou A,
    7. et al

    ; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010;363(12):1107-1116.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Bauer PR,
    2. Kashyap R,
    3. Abraham RS,
    4. Peikert T,
    5. Gajic O

    . Accuracy of waste blood measurement in critically ill patients. Intensive Care Med 2011;37(4):721-722.

    OpenUrlPubMed
25. 25.↵
    1. Kor DJ,
    2. Carter RE,
    3. Park PK,
    4. Festic E,
    5. Banner-Goodspeed VM,
    6. Hinds R,
    7. et al

    ; U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention with Aspirin Study Group (USCIITG: LIPS-A). Effect of aspirin on development of ARDS in at-risk patients presenting to the emergency department: the LIPS-a randomized clinical trial. JAMA 2016;315(22):2406-2414.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Wenger DS,
    2. Triplette M,
    3. Crothers K,
    4. Cheng GS,
    5. Hill JA,
    6. Milano F,
    7. et al

    . Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2020;26(2):413-420.

    OpenUrl
27. 27.↵
    1. Shorr AF,
    2. Abbott KC,
    3. Agadoa LY

    . Acute respiratory distress syndrome after kidney transplantation: epidemiology, risk factors, and outcomes. Crit Care Med 2003;31(5):1325-1330.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Cortegiani A,
    2. Madotto F,
    3. Gregoretti C,
    4. Bellani G,
    5. Laffey JG,
    6. Pham T,
    7. et al

    ; LUNG SAFE Investigators and the ESICM Trials Group. Immunocompromised patients with acute respiratory distress syndrome: secondary analysis of the LUNG SAFE database. Crit Care 2018;22(1):157.

    OpenUrlPubMed
29. 29.↵
    1. Mokart D,
    2. Darmon M,
    3. Schellongowski P,
    4. Pickkers P,
    5. Soares M,
    6. Rello J,
    7. et al

    ; Efraim investigators and the Nine-I study group. Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status. Ann Intensive Care 2020;10(1):146.

    OpenUrl
30. 30.↵
    1. Shen J,
    2. Hu Y,
    3. Zhao H,
    4. Xiao Z,
    5. Zhao L,
    6. Du A,
    7. et al

    . Risk factors of noninvasive ventilation failure in hematopoietic stem cell transplantation patients with acute respiratory distress syndrome. Ther Adv Respir Dis 2020;14:1753466620914220.

    OpenUrlPubMed
31. 31.↵
    1. Demoule A,
    2. Antonelli M,
    3. Schellongowski P,
    4. Pickkers P,
    5. Soares M,
    6. Meyhoff T,
    7. et al

    ; EFRAIM Investigators. Respiratory mechanics and outcomes in immunocompromised patients with ARDS: a secondary analysis of the EFRAIM study. Chest 2020;158(5):1947-1957.

    OpenUrl
32. 32.↵
    1. Egi M,
    2. Bellomo R,
    3. Stachowski E,
    4. French CJ,
    5. Hart GK,
    6. Taori G,
    7. et al

    . Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 2010;85(3):217-224.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Kushimoto S,
    2. Abe T,
    3. Ogura H,
    4. Shiraishi A,
    5. Saitoh D,
    6. Fujishima S,
    7. et al

    ; on behalf of JAAM FORECAST group. Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis. PloS One 2020;15(3):e0229919.

    OpenUrl
34. 34.↵
    1. Duprez F,
    2. Mashayekhi S,
    3. Cuvelier G,
    4. Legrand A,
    5. Reychler G

    . A new formula for predicting the fraction of delivered oxygen during low-flow oxygen therapy. Respir Care 2018;63(12):1528-1534.

    OpenUrlAbstract/FREE Full Text